Optilume Urethral Drug Coated Balloon

FDA Premarket Approval P210020

Pre-market Approval Supplement Details

The optilume® urethral drug coated balloon is used to treat patients with obstructive urinary symptoms associated with anterior urethral stricture. It is designed to be used in adult males for urethral strictures of less than or equal to 3 cm in length.

DeviceOptilume Urethral Drug Coated Balloon
Generic NameCatheter, Balloon, Urethral, Drug-coated
ApplicantUrotronic, Inc.
Date Received2021-05-11
Decision Date2021-12-03
PMAP210020
SupplementS
Product CodeQRH 
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product Yes
Applicant Address Urotronic, Inc. 2495 Xenium Lane minneapolis, MN 55441

Supplemental Filings

Supplement NumberDateSupplement Type
P210020Original Filing
S006 2022-08-30 Normal 180 Day Track No User Fee
S005 2022-05-12 Normal 180 Day Track No User Fee
S004 2022-02-24 Real-time Process
S003 2022-01-05 Normal 180 Day Track No User Fee
S002 2021-12-28 Normal 180 Day Track No User Fee
S001 2021-12-20 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00853095008334 P210020 000
00853095008327 P210020 000
00853095008310 P210020 000
00853095008303 P210020 000
00853095008297 P210020 000
00853095008280 P210020 000
00853095008273 P210020 000
00853095008242 P210020 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.